Thank you for the series of comments and questions. I certainly recognise that there’s more to do in the areas both of survivor rehabilitation and prevention—in each of these areas. That’s why we have this approach—bringing together people who have a direct interest in this from outside Government, within Government and the NHS too. The example you started with of stroke is a good example of where the implementation group had helped to be part of delivering improvement. There are also difficult questions for all of us as well about the change in the nature of delivery, because the improvement, for example, in Aneurin Bevan Local Health Board, came on the back of a difficult service redesign, and that’s not easy. But if you talk to the national clinical lead for stroke in Bronglais hospital, he will say that there needs to be a smaller number of hyper-acute units. Now, that means difficult choices for people around Wales. If we’re going to concentrate and specialise that form of service, then it’s got to be done on the basis that there is a real and clear evidence base that it will improve outcomes, as there will be difficult challenges if people are expected to travel further for that treatment. But, ultimately, if the evidence is that there is a better chance of them surviving, and a better chance of them having effective rehabilitation as a result, that’s something that the service will need to deliver.

On your broader points—the points that you made around cancer—actually, it’s a remarkable success story for the national health service to sustain the increase in demand on the cancer services, and to still see as many people as they do. We are seeing record numbers of people within time, as more people have a diagnosis of cancer, and more people are treated more successfully than ever before. I don’t think it hurts to remind ourselves that survival rates are now over 70 per cent at one year, and over 50 per cent after five years. The challenge for us is how we make further progress. The next stage of the delivery plan, I think, will help to set that out for us: in particular, some of the areas we’ve highlighted, for example, diagnosis and earlier access. But, you know, that’s—. We’re not just learning from within the UK. So, part of the work that’s been done has been to go out to Denmark and look at what they’ve done successfully over a period of time to improve their own survival rates too. This does come back to how we share learning, but not just talk about the shared learning, but how we get on and implement it. That’s been a very consistent message from myself and leadership here at Government level—that we expect to see greater consistency in delivering upon improvements and greater pace in delivering them across the country too.